ENTERA BIO IS-0000769 Net Asset Momentum
ENTERA BIO IS-0000769 net asset momentum. ENTERA BIO IS-0000769 (5DT) recorded a net asset momentum of 62.1% as of December 2025, with net assets of €13.10 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore 5DT cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of ENTERA BIO IS-0000769 (2021–2025)
Net asset momentum of ENTERA BIO IS-0000769 from 2021 to 2025. This chart tracks ENTERA BIO IS-0000769's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is +62.1%, with net assets of €13.10 Million EUR as of December 2025. See ENTERA BIO IS-0000769 (5DT) shareholders funds for net asset value and shareholders' equity analysis.
ENTERA BIO IS-0000769 Net Asset Momentum by Year (2021–2025)
ENTERA BIO IS-0000769 net asset momentum by year from 2021 to 2025. The table below shows the complete annual net asset history for ENTERA BIO IS-0000769 from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see 5DT stock market capitalisation.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €13.10 Million | €15.99 Million | €2.89 Million | ▲ +62.1% |
| 2024 | €8.08 Million | €9.39 Million | €1.31 Million | ▼ -22.2% |
| 2023 | €10.39 Million | €11.77 Million | €1.38 Million | ▼ -11.6% |
| 2022 | €11.75 Million | €13.13 Million | €1.37 Million | ▼ -47.9% |
| 2021 | €22.57 Million | €25.99 Million | €3.42 Million | — |